1 小时
Sinar Daily on MSNChoice awaits genetic cancer patients as middle age beckonsAlthough Nor Haryati has finished her treatment, doctors were loathe to say she was cancer-free due to the genetic mutation.
2 天
The Forward on MSNHow one Jewish geneticist turned a family tragedy into a lifesaving mission.February is American Heart Month, which is an appropriate time to learn how genetic testing can protect your family.
Bianca Balti has left for Italy. The top model, who lives in the United States, posted a photo of herself on Instagram on a ...
Hindustan Times on MSN17 小时
What to do if your body is resisting cancer treatment? Advanced therapies, personalised ...Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!
While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...
A global study revealed that young breast cancer patients with high risk BRCA mutations can have their risk of cancer recurrence reduced significantly by undergoing mastectomy and/or ovary removal, of ...
【导读】帕博西尼(Palbociclib)是一种CDK4/6抑制剂,在治疗HR+乳腺癌中发挥着至关重要的作用。然而,palbociclib的耐药性是一个值得进一步研究的重大问题。团队的研究发现,TMEM45A是palbociclib耐药性的潜在驱动因 ...
Former World No.1 Chris Evert was diagnosed with stage 1C ovarian cancer in 2022. She battled through the disease with strength and resilience, successfully overcoming it.
Laurie Ratliff was diagnosed with metastatic breast cancer 25 years ago, and she’s continuing to beat the odds while ...
2 天
Money Talks News on MSNScientists Crack the Code on BRCA2: New Hope for Cancer PatientsScientists have made a groundbreaking discovery in understanding the BRCA2 gene, offering new hope for cancer patients and those at high risk of developing the disease.
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
【导读】免疫检查点阻断(ICB)疗法通过靶向程序性细胞死亡配体1(PD-L1)/程序性细胞死亡蛋白1(PD-1)轴以及细胞毒性T淋巴细胞相关蛋白4(CTLA-4),已在多种癌症类型中展现出显著的临床效果。然而,目前只有少数患者能够从ICB疗法中获益, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果